Premium
Clinicians should stop prescribing sildenafil for fetal growth restriction (FGR): comment from the STRIDER Consortium
Author(s) -
Groom K. M.,
Ganzevoort W.,
Alfirevic Z.,
Lim K.,
Papageorghiou A. T.
Publication year - 2018
Publication title -
ultrasound in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.202
H-Index - 141
eISSN - 1469-0705
pISSN - 0960-7692
DOI - 10.1002/uog.19186
Subject(s) - medicine , sildenafil , intrauterine growth restriction , pregnancy , fetal growth , data monitoring committee , randomized controlled trial , clinical trial , placebo , fetus , intensive care medicine , pediatrics , alternative medicine , pathology , biology , genetics